Trinity Biotech plc ( TRIB) - Key Metrics
TRIB Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $17.82 | -$28.12 | -$2.50 | -$2.48 |
| 2025Q3 | $22.91 | -$8.22 | -$0.11 | -$0.12 |
| 2025Q2 | $17.67 | -$9.74 | -$2.69 | -$2.75 |
| 2025Q1 | $12.42 | -$14.43 | -$4.86 | -$4.95 |
| 2024Q4 | $33.56 | -$35.89 | $7.09 | $1.30 |
TRIB Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | 0% | -0.21 |
| 2025Q3 | 0% | -0.95 |
| 2025Q2 | 0% | -0.50 |
| 2025Q1 | 0% | -0.30 |
| 2024Q4 | 0% | -0.18 |
TRIB
Price: $7.32
52 week price:
Payout Ratio Range:
Earnings Per Share: -60.00 USD
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Country: Ireland
Volume: 16000
Ebitda: 1.7 millionMarket Capitalization: 7.4 million